Immune system diseases

NICE recommends first ever treatment for severe dust mite allergy

Results from clinical trials have revealed that 12 SQ-HDM SLIT benefits patients with dust mite allergy symptoms that cannot be treated with steroid nasal sprays or antihistamines.…

Look out for PANDAS in the UK

'Paediatric autoimmune neuropsychiatric disorder associated with streptococcal infection' (PANDAS) is a neuropsychiatric disease found in children. The onset is sudden and is characterised by symptoms akin with obsessive compulsive disorder (OCD), such as tics and anxiety (including separation anxie…

NHS rolls out new multiple sclerosis injection that cuts treatment time by 90%

The NHS will be one of the first healthcare systems in the world to offer the new injection in the “coming weeks”.…

Our experience as pharmacists in ‘SPACE’

Three pharmacists describe their experience working on the multicentre SPACE study, which aims to tackle false penicillin allergy labels.…

Juvenile idiopathic arthritis: recognition, diagnosis and conventional pharmacological management

Juvenile idiopathic arthritis is the most common chronic childhood rheumatic disease. Pharmacists are a vital part of the multidisciplinary team and should be aware of the considerations for pharmacological management.…

Pharmacist coordinating UK participation in global penicillin allergy labelling study

Royal Cornwall Hospital NHS Trust will be the first UK health service to join the ‘International Network of Antibiotic Allergy Nations’ study.…

First drug for severe alopecia recommended by NICE could benefit 14,000 patients

Ritlecitinib (Litfulo; Pfizer), a once-daily oral pill, is the first licensed treatment recommended for patients with alopecia areata.…

Rhinosinusitis: symptoms, diagnosis and management in community pharmacy

Pharmacists are likely to encounter patients concerned about nasal congestion, and should know when it is appropriate to treat and when to refer.…

Rheumatoid arthritis: management

An overview of the medicines used for symptom control and disease modification, with consideration given to non-pharmacological approaches that support management of rheumatoid arthritis.…

Newborn genome screening: a step too far?

A project to screen the genomes of 100,000 babies for rare diseases is set to begin recruiting in 2023, but it will face ethical and societal challenges.…